Spencer Kimber is an Investment Principal at Shannon Life Sciences, where he leads the private capital investment strategy across biopharma venture capital, healthcare services, and CPG. With 12+ years of experience spanning private equity, venture capital, corporate development, and strategy consulting, Spencer has led or advised on over $5B in transactions including acquisitions, investments, and strategic partnerships across the healthcare and life sciences ecosystem. Prior to Shannon, he served as Associate Principal at IQVIA advising PE and VC firms on healthcare investments, and as Director of Strategy and Corporate Development at Oracle Cerner, where he led M&A and corporate venture capital initiatives. Spencer has built LLM-powered research infrastructure to automate deal screening, pipeline analysis, and competitive intelligence -- bridging his investment expertise with emerging AI capabilities. He holds an MBA from Cornell University, an MS from Johns Hopkins University (Regulatory Science/Biotechnology), and a BA from UNC Wilmington (Economics & Chemistry).